GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Equity-to-Asset

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Equity-to-Asset : 0.08 (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Zhong Yuan Bio-Technology Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $0.25 Mil. Zhong Yuan Bio-Technology Holdings's Total Assets for the quarter that ended in Sep. 2023 was $3.22 Mil. Therefore, Zhong Yuan Bio-Technology Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.08.

The historical rank and industry rank for Zhong Yuan Bio-Technology Holdings's Equity-to-Asset or its related term are showing as below:

ZHYBF' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.15   Med: 0.38   Max: 0.65
Current: 0.08

During the past 8 years, the highest Equity to Asset Ratio of Zhong Yuan Bio-Technology Holdings was 0.65. The lowest was -0.15. And the median was 0.38.

ZHYBF's Equity-to-Asset is ranked worse than
92.39% of 1918 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs ZHYBF: 0.08

Zhong Yuan Bio-Technology Holdings Equity-to-Asset Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Equity-to-Asset Chart

Zhong Yuan Bio-Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial 0.77 0.65 0.43 0.33 -0.15

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.33 0.18 -0.15 0.08

Competitive Comparison of Zhong Yuan Bio-Technology Holdings's Equity-to-Asset

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhong Yuan Bio-Technology Holdings's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's Equity-to-Asset falls into.



Zhong Yuan Bio-Technology Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Zhong Yuan Bio-Technology Holdings's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=-0.347/2.28
=-0.15

Zhong Yuan Bio-Technology Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=0.253/3.224
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhong Yuan Bio-Technology Holdings  (OTCPK:ZHYBF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Zhong Yuan Bio-Technology Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG
Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.
Executives
Tingting Chang director, 10 percent owner, officer: CEO RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy director, 10 percent owner, officer: president,secretary,treasurer 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: Vice President 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines